D-lactic acidosis: Difference between revisions

(Formatting: removed excessive bold)
(Strip excess bold)
 
Line 1: Line 1:
==Background==
==Background==
*D-lactic acidosis (D-lactate encephalopathy) is a rare cause of '''anion gap metabolic acidosis with neurologic symptoms''' that occurs primarily in patients with '''short bowel syndrome (SBS)''' and an intact colon<ref name="kowlgi">Kowlgi NG, Chhabra L. D-lactic acidosis: an underrecognized complication of short bowel syndrome. ''Gastroenterol Res Pract''. 2015;2015:476215. PMID 25977687.</ref>
*D-lactic acidosis (D-lactate encephalopathy) is a rare cause of anion gap metabolic acidosis with neurologic symptoms that occurs primarily in patients with short bowel syndrome (SBS) and an intact colon<ref name="kowlgi">Kowlgi NG, Chhabra L. D-lactic acidosis: an underrecognized complication of short bowel syndrome. ''Gastroenterol Res Pract''. 2015;2015:476215. PMID 25977687.</ref>
*Pathophysiology:
*Pathophysiology:
**Humans produce almost exclusively '''L-lactate'''; '''D-lactate''' is the mirror-image (enantiomer) produced by bacterial metabolism
**Humans produce almost exclusively L-lactate; D-lactate is the mirror-image (enantiomer) produced by bacterial metabolism
**In SBS, unabsorbed carbohydrates reach the colon where they are fermented by colonic bacteria (''Lactobacillus'', ''Streptococcus bovis'', and other acid-resistant organisms) into organic acids including '''D-lactic acid'''
**In SBS, unabsorbed carbohydrates reach the colon where they are fermented by colonic bacteria (''Lactobacillus'', ''Streptococcus bovis'', and other acid-resistant organisms) into organic acids including D-lactic acid
**The resulting acidic colonic environment further favors overgrowth of D-lactate-producing organisms → '''vicious cycle''' of escalating D-lactate production<ref name="kowlgi"/>
**The resulting acidic colonic environment further favors overgrowth of D-lactate-producing organisms → vicious cycle of escalating D-lactate production<ref name="kowlgi"/>
**Humans metabolize D-lactate much more slowly than L-lactate (via D-2-hydroxy acid dehydrogenase), so D-lactate accumulates in the blood
**Humans metabolize D-lactate much more slowly than L-lactate (via D-2-hydroxy acid dehydrogenase), so D-lactate accumulates in the blood
**D-lactate crosses the blood-brain barrier and causes neurologic dysfunction<ref name="petersen">Petersen C. D-lactic acidosis. ''Nutr Clin Pract''. 2005;20(6):634-645. PMID 16306300.</ref>
**D-lactate crosses the blood-brain barrier and causes neurologic dysfunction<ref name="petersen">Petersen C. D-lactic acidosis. ''Nutr Clin Pract''. 2005;20(6):634-645. PMID 16306300.</ref>
Line 11: Line 11:
**Small intestinal bacterial overgrowth (SIBO)
**Small intestinal bacterial overgrowth (SIBO)
**Rarely: diabetes mellitus with intestinal dysmotility, chronic antibiotic use altering gut flora
**Rarely: diabetes mellitus with intestinal dysmotility, chronic antibiotic use altering gut flora
*Episodes are typically precipitated by '''high carbohydrate meals''' (provides substrate for bacterial fermentation)<ref name="uribarri">Uribarri J, Oh MS, Carroll HJ. D-lactic acidosis: a review of clinical presentation, biochemical features, and pathophysiologic mechanisms. ''Medicine (Baltimore)''. 1998;77(2):73-82. PMID 9556700.</ref>
*Episodes are typically precipitated by high carbohydrate meals (provides substrate for bacterial fermentation)<ref name="uribarri">Uribarri J, Oh MS, Carroll HJ. D-lactic acidosis: a review of clinical presentation, biochemical features, and pathophysiologic mechanisms. ''Medicine (Baltimore)''. 1998;77(2):73-82. PMID 9556700.</ref>
*The key diagnostic challenge: Standard laboratory L-lactate assays '''do NOT detect D-lactate''' — a normal reported "lactic acid" does not exclude D-lactic acidosis<ref name="bustos">Bustos D, Pernas JC, Perez-Ayuso E, et al. D-lactic acidosis in short-bowel syndrome managed with antibiotics and probiotics. ''J Pediatr Surg''. 2004;39(2):e5. PMID 15065046.</ref>
*The key diagnostic challenge: Standard laboratory L-lactate assays '''do NOT detect D-lactate''' — a normal reported "lactic acid" does not exclude D-lactic acidosis<ref name="bustos">Bustos D, Pernas JC, Perez-Ayuso E, et al. D-lactic acidosis in short-bowel syndrome managed with antibiotics and probiotics. ''J Pediatr Surg''. 2004;39(2):e5. PMID 15065046.</ref>


==Clinical Features==
==Clinical Features==
*Presentation is characterized by '''recurrent episodic encephalopathy''' and '''metabolic acidosis''' — typically following carbohydrate-rich meals
*Presentation is characterized by recurrent episodic encephalopathy and metabolic acidosis — typically following carbohydrate-rich meals
*Neurologic symptoms predominate (present in virtually all reported cases):<ref name="kowlgi"/>
*Neurologic symptoms predominate (present in virtually all reported cases):<ref name="kowlgi"/>
**Altered mental status (confusion, disorientation, lethargy → stupor → coma)
**Altered mental status (confusion, disorientation, lethargy → stupor → coma)
Line 29: Line 29:
**Abdominal pain/distension (often chronic from underlying SBS)
**Abdominal pain/distension (often chronic from underlying SBS)
**Diarrhea
**Diarrhea
*Classic pattern: Symptoms develop '''hours after a high-carbohydrate meal''' in a patient with known SBS, and resolve with fasting and correction of acidosis
*Classic pattern: Symptoms develop hours after a high-carbohydrate meal in a patient with known SBS, and resolve with fasting and correction of acidosis
*Neurologic symptoms may occur '''without significant acidosis''' in some cases, suggesting direct neurotoxicity of D-lactate beyond its contribution to acidosis<ref name="kowlgi"/>
*Neurologic symptoms may occur without significant acidosis in some cases, suggesting direct neurotoxicity of D-lactate beyond its contribution to acidosis<ref name="kowlgi"/>
*Episodes are '''recurrent''' — patients often present repeatedly before the diagnosis is made
*Episodes are recurrent — patients often present repeatedly before the diagnosis is made


==Differential Diagnosis==
==Differential Diagnosis==
Line 48: Line 48:
**[[Sepsis]] / bacteremia (SBS patients are at risk for catheter-related bloodstream infections)
**[[Sepsis]] / bacteremia (SBS patients are at risk for catheter-related bloodstream infections)
**[[Mesenteric Ischemia]] (recurrent in SBS)
**[[Mesenteric Ischemia]] (recurrent in SBS)
*Intoxication: Presentation mimics alcohol intoxication — patients may be dismissed as inebriated; '''serum ethanol level will be negative'''
*Intoxication: Presentation mimics alcohol intoxication — patients may be dismissed as inebriated; serum ethanol level will be negative
*[[Ethanol Toxicity|Alcoholic ketoacidosis]]
*[[Ethanol Toxicity|Alcoholic ketoacidosis]]


Line 55: Line 55:
*BMP/CMP: Anion gap metabolic acidosis (elevated anion gap); electrolytes, bicarbonate, BUN/creatinine, glucose
*BMP/CMP: Anion gap metabolic acidosis (elevated anion gap); electrolytes, bicarbonate, BUN/creatinine, glucose
*ABG/VBG: Confirm metabolic acidosis; calculate anion gap
*ABG/VBG: Confirm metabolic acidosis; calculate anion gap
*Standard L-lactate level: May be normal or mildly elevated — '''a normal L-lactate in the setting of unexplained AGMA in a SBS patient should raise suspicion for D-lactic acidosis'''<ref name="kowlgi"/>
*Standard L-lactate level: May be normal or mildly elevated — a normal L-lactate in the setting of unexplained AGMA in a SBS patient should raise suspicion for D-lactic acidosis<ref name="kowlgi"/>
*D-lactate level: '''This is the confirmatory test'''
*D-lactate level: This is the confirmatory test
**Normal: < 0.25 mmol/L
**Normal: < 0.25 mmol/L
**Diagnostic: > 3 mmol/L<ref name="bustos"/>
**Diagnostic: > 3 mmol/L<ref name="bustos"/>
Line 71: Line 71:


===Diagnosis===
===Diagnosis===
*Diagnosis is primarily '''clinical''' — suspect D-lactic acidosis when:
*Diagnosis is primarily clinical — suspect D-lactic acidosis when:
**Anion gap metabolic acidosis PLUS '''encephalopathy/neurologic symptoms''' PLUS '''history of SBS or intestinal malabsorption''' PLUS '''normal or mildly elevated L-lactate'''
**Anion gap metabolic acidosis PLUS encephalopathy/neurologic symptoms PLUS history of SBS or intestinal malabsorption PLUS normal or mildly elevated L-lactate
*The '''"lactate gap"''' — unexplained anion gap metabolic acidosis with normal L-lactate — is the hallmark laboratory clue<ref name="petersen"/>
*The "lactate gap" — unexplained anion gap metabolic acidosis with normal L-lactate — is the hallmark laboratory clue<ref name="petersen"/>
*Confirmed by serum D-lactate > 3 mmol/L, but treatment should '''not be delayed''' pending this result
*Confirmed by serum D-lactate > 3 mmol/L, but treatment should not be delayed pending this result
*Other organic acids (D-2-hydroxyisovaleric acid, D-2-hydroxyisocaproic acid) may contribute to the anion gap but are not routinely measured
*Other organic acids (D-2-hydroxyisovaleric acid, D-2-hydroxyisocaproic acid) may contribute to the anion gap but are not routinely measured


==Management==
==Management==
===Acute Treatment===
===Acute Treatment===
*NPO / fasting: Eliminates carbohydrate substrate for bacterial D-lactate production — '''this is the single most important acute intervention'''<ref name="kowlgi"/>
*NPO / fasting: Eliminates carbohydrate substrate for bacterial D-lactate production — this is the single most important acute intervention<ref name="kowlgi"/>
**IV fluids for hydration during fasting period
**IV fluids for hydration during fasting period
**Typically 24 hours of fasting followed by slow reintroduction of a '''low-carbohydrate diet'''
**Typically 24 hours of fasting followed by slow reintroduction of a low-carbohydrate diet
*IV sodium bicarbonate: For significant metabolic acidosis (pH < 7.2 or hemodynamically significant); correct acidosis gradually
*IV sodium bicarbonate: For significant metabolic acidosis (pH < 7.2 or hemodynamically significant); correct acidosis gradually
*IV thiamine: 100 mg IV — administer empirically in all malnourished SBS patients (thiamine deficiency may coexist and mimics/worsens encephalopathy; thiamine is also a cofactor in D-lactate metabolism)<ref name="petersen"/>
*IV thiamine: 100 mg IV — administer empirically in all malnourished SBS patients (thiamine deficiency may coexist and mimics/worsens encephalopathy; thiamine is also a cofactor in D-lactate metabolism)<ref name="petersen"/>
Line 90: Line 90:
**Choice is often empiric; rotation may be needed for recurrent episodes
**Choice is often empiric; rotation may be needed for recurrent episodes
*Correct electrolyte abnormalities
*Correct electrolyte abnormalities
*'''Avoid Lactated Ringer's solution''' — while LR contains only L-lactate and should not worsen D-lactic acidosis, normal saline is preferred to avoid any confusion
*Avoid Lactated Ringer's solution — while LR contains only L-lactate and should not worsen D-lactic acidosis, normal saline is preferred to avoid any confusion


===Prevention of Recurrence===
===Prevention of Recurrence===
*Low-carbohydrate diet: Reduce simple sugars and refined carbohydrates to limit substrate for bacterial fermentation — '''cornerstone of long-term management'''<ref name="uribarri"/>
*Low-carbohydrate diet: Reduce simple sugars and refined carbohydrates to limit substrate for bacterial fermentation — cornerstone of long-term management<ref name="uribarri"/>
*Probiotics: Non-D-lactate-producing strains (e.g. ''Lactobacillus rhamnosus GG'', ''Saccharomyces boulardii'') to recolonize with favorable flora — evidence is limited but promising<ref name="bustos"/>
*Probiotics: Non-D-lactate-producing strains (e.g. ''Lactobacillus rhamnosus GG'', ''Saccharomyces boulardii'') to recolonize with favorable flora — evidence is limited but promising<ref name="bustos"/>
*Intermittent or cycling enteral antibiotics: Reduce bacterial overgrowth
*Intermittent or cycling enteral antibiotics: Reduce bacterial overgrowth
Line 119: Line 119:
**Provide dietary counseling: avoid high-sugar/high-carbohydrate meals
**Provide dietary counseling: avoid high-sugar/high-carbohydrate meals
**Educate patient/family on recognition of recurrent episodes and need for early ED presentation
**Educate patient/family on recognition of recurrent episodes and need for early ED presentation
*Prognosis: With appropriate treatment, acute episodes typically resolve within '''24–48 hours''' of fasting and supportive care; long-term prognosis depends on the underlying SBS and dietary adherence<ref name="kowlgi"/>
*Prognosis: With appropriate treatment, acute episodes typically resolve within 24–48 hours of fasting and supportive care; long-term prognosis depends on the underlying SBS and dietary adherence<ref name="kowlgi"/>


==See Also==
==See Also==

Latest revision as of 09:29, 22 March 2026

Background

  • D-lactic acidosis (D-lactate encephalopathy) is a rare cause of anion gap metabolic acidosis with neurologic symptoms that occurs primarily in patients with short bowel syndrome (SBS) and an intact colon[1]
  • Pathophysiology:
    • Humans produce almost exclusively L-lactate; D-lactate is the mirror-image (enantiomer) produced by bacterial metabolism
    • In SBS, unabsorbed carbohydrates reach the colon where they are fermented by colonic bacteria (Lactobacillus, Streptococcus bovis, and other acid-resistant organisms) into organic acids including D-lactic acid
    • The resulting acidic colonic environment further favors overgrowth of D-lactate-producing organisms → vicious cycle of escalating D-lactate production[1]
    • Humans metabolize D-lactate much more slowly than L-lactate (via D-2-hydroxy acid dehydrogenase), so D-lactate accumulates in the blood
    • D-lactate crosses the blood-brain barrier and causes neurologic dysfunction[2]
  • Conditions associated with D-lactic acidosis:
    • Short bowel syndrome (most common) — from surgical resection (Crohn's disease, mesenteric ischemia, volvulus, NEC, trauma), congenital abnormalities, or historical jejunoileal bypass for obesity[1]
    • Small intestinal bacterial overgrowth (SIBO)
    • Rarely: diabetes mellitus with intestinal dysmotility, chronic antibiotic use altering gut flora
  • Episodes are typically precipitated by high carbohydrate meals (provides substrate for bacterial fermentation)[3]
  • The key diagnostic challenge: Standard laboratory L-lactate assays do NOT detect D-lactate — a normal reported "lactic acid" does not exclude D-lactic acidosis[4]

Clinical Features

  • Presentation is characterized by recurrent episodic encephalopathy and metabolic acidosis — typically following carbohydrate-rich meals
  • Neurologic symptoms predominate (present in virtually all reported cases):[1]
    • Altered mental status (confusion, disorientation, lethargy → stupor → coma)
    • Slurred speech
    • Ataxia and gait disturbance (often described as appearing "intoxicated")
    • Impaired motor coordination
    • Nystagmus
    • Irritability, hostile/aggressive/bizarre behavior
    • Weakness
    • Headache
  • GI symptoms:
    • Nausea, vomiting
    • Abdominal pain/distension (often chronic from underlying SBS)
    • Diarrhea
  • Classic pattern: Symptoms develop hours after a high-carbohydrate meal in a patient with known SBS, and resolve with fasting and correction of acidosis
  • Neurologic symptoms may occur without significant acidosis in some cases, suggesting direct neurotoxicity of D-lactate beyond its contribution to acidosis[1]
  • Episodes are recurrent — patients often present repeatedly before the diagnosis is made

Differential Diagnosis

Evaluation

Workup

  • BMP/CMP: Anion gap metabolic acidosis (elevated anion gap); electrolytes, bicarbonate, BUN/creatinine, glucose
  • ABG/VBG: Confirm metabolic acidosis; calculate anion gap
  • Standard L-lactate level: May be normal or mildly elevated — a normal L-lactate in the setting of unexplained AGMA in a SBS patient should raise suspicion for D-lactic acidosis[1]
  • D-lactate level: This is the confirmatory test
    • Normal: < 0.25 mmol/L
    • Diagnostic: > 3 mmol/L[4]
    • This is a send-out test — NOT available on routine chemistry panels or point-of-care testing; results may take days
    • Diagnosis must often be made clinically before results return
  • Serum ketones: To exclude DKA and alcoholic ketoacidosis
  • Serum ethanol, acetaminophen, salicylate levels: Exclude co-ingestants and toxic alcohols
  • Serum osmolality and osmolar gap: Exclude toxic alcohol ingestion
  • CBC: Leukocytosis may suggest alternative diagnosis (sepsis, ischemia)
  • LFTs, ammonia: Exclude hepatic encephalopathy
  • Thiamine level: Consider in malnourished SBS patients (Wernicke can coexist)
  • Blood cultures: If febrile or concern for line sepsis
  • CT abdomen: Consider to exclude bowel obstruction, bowel dilatation, or ischemia as alternative/contributing diagnoses

Diagnosis

  • Diagnosis is primarily clinical — suspect D-lactic acidosis when:
    • Anion gap metabolic acidosis PLUS encephalopathy/neurologic symptoms PLUS history of SBS or intestinal malabsorption PLUS normal or mildly elevated L-lactate
  • The "lactate gap" — unexplained anion gap metabolic acidosis with normal L-lactate — is the hallmark laboratory clue[2]
  • Confirmed by serum D-lactate > 3 mmol/L, but treatment should not be delayed pending this result
  • Other organic acids (D-2-hydroxyisovaleric acid, D-2-hydroxyisocaproic acid) may contribute to the anion gap but are not routinely measured

Management

Acute Treatment

  • NPO / fasting: Eliminates carbohydrate substrate for bacterial D-lactate production — this is the single most important acute intervention[1]
    • IV fluids for hydration during fasting period
    • Typically 24 hours of fasting followed by slow reintroduction of a low-carbohydrate diet
  • IV sodium bicarbonate: For significant metabolic acidosis (pH < 7.2 or hemodynamically significant); correct acidosis gradually
  • IV thiamine: 100 mg IV — administer empirically in all malnourished SBS patients (thiamine deficiency may coexist and mimics/worsens encephalopathy; thiamine is also a cofactor in D-lactate metabolism)[2]
  • Enteral antibiotics: Target D-lactate-producing colonic flora[1]
    • Metronidazole (oral)
    • Oral vancomycin
    • Oral neomycin or kanamycin
    • Choice is often empiric; rotation may be needed for recurrent episodes
  • Correct electrolyte abnormalities
  • Avoid Lactated Ringer's solution — while LR contains only L-lactate and should not worsen D-lactic acidosis, normal saline is preferred to avoid any confusion

Prevention of Recurrence

  • Low-carbohydrate diet: Reduce simple sugars and refined carbohydrates to limit substrate for bacterial fermentation — cornerstone of long-term management[3]
  • Probiotics: Non-D-lactate-producing strains (e.g. Lactobacillus rhamnosus GG, Saccharomyces boulardii) to recolonize with favorable flora — evidence is limited but promising[4]
  • Intermittent or cycling enteral antibiotics: Reduce bacterial overgrowth
  • Optimize SBS management: GI/nutrition consultation for intestinal rehabilitation, dietary counseling, parenteral nutrition adjustment
  • Surgical options (refractory cases): Intestinal lengthening procedures, small bowel transplant, or colectomy (eliminates the site of D-lactate production — last resort)[1]

Disposition

  • Admit:
    • All patients with suspected or confirmed D-lactic acidosis
    • Significant metabolic acidosis requiring IV bicarbonate
    • Altered mental status (monitor for airway compromise)
    • Inability to tolerate oral intake
    • Need for IV hydration and serial lab monitoring
  • ICU admission:
    • Severe encephalopathy (GCS significantly depressed, inability to protect airway)
    • Hemodynamic instability
    • Severe acidosis (pH < 7.1)
  • Consultations:
    • GI / nutrition: For long-term SBS management, dietary counseling, and prevention of recurrence
    • Medical toxicology: If diagnostic uncertainty regarding anion gap etiology
    • Surgery: If bowel obstruction, ischemia, or surgical SBS management is being considered
  • Discharge:
    • Once neurologic symptoms have fully resolved, acidosis has corrected, and patient tolerates oral low-carbohydrate diet
    • Arrange close GI follow-up
    • Provide dietary counseling: avoid high-sugar/high-carbohydrate meals
    • Educate patient/family on recognition of recurrent episodes and need for early ED presentation
  • Prognosis: With appropriate treatment, acute episodes typically resolve within 24–48 hours of fasting and supportive care; long-term prognosis depends on the underlying SBS and dietary adherence[1]

See Also

External Links

References

  1. ↑ 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 1.9 Kowlgi NG, Chhabra L. D-lactic acidosis: an underrecognized complication of short bowel syndrome. Gastroenterol Res Pract. 2015;2015:476215. PMID 25977687.
  2. ↑ 2.0 2.1 2.2 Petersen C. D-lactic acidosis. Nutr Clin Pract. 2005;20(6):634-645. PMID 16306300.
  3. ↑ 3.0 3.1 Uribarri J, Oh MS, Carroll HJ. D-lactic acidosis: a review of clinical presentation, biochemical features, and pathophysiologic mechanisms. Medicine (Baltimore). 1998;77(2):73-82. PMID 9556700.
  4. ↑ 4.0 4.1 4.2 Bustos D, Pernas JC, Perez-Ayuso E, et al. D-lactic acidosis in short-bowel syndrome managed with antibiotics and probiotics. J Pediatr Surg. 2004;39(2):e5. PMID 15065046.
Retrieved from "https://www.wikem.org/w/index.php?title=D-lactic_acidosis&oldid=389200"